MXCT — MAXCYTE, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-07-30.
Performance
Technicals
Others in Healthcare
Measured signals that fired on MXCT
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-17 | DOUGLAS RICHARD Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | Brooke William W Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | BALTHROP PATRICK J Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | Al-Wakeel Yasir B. Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | Erck Stanley C Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | Hemrajani Rekha Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | Johnston John Joseph Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-06-17 | Collins Cynthia Director | Grant or award | 30.4K | 0.00 | 0 |
| 2026-04-15 | Ahuja Parmeet Chief Financial Officer | Grant or award | 187.5K | 0.00 | 0 |
| 2026-03-27 | Masoud Maher President and CEO | Grant or award | 300.0K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 6.2M | 8.8M |
| Capricorn Fund Managers Ltd | 5.8M | 8.2M |
| Vitruvian Partners LLP | 3.5M | 5.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | 4.0M |
| MORGAN STANLEY | 2.6M | 3.7M |
| Mudita Advisors LLP | 2.4M | 3.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.9M | 2.8M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | 2.4M |
| STATE STREET CORP | 1.5M | 2.2M |
| Brooklands Fund Management Ltd | 1.5M | 2.2M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- MaxCyte (MXCT) Q2 2026 Earnings Call Transcript · 2026-08-19
- MaxCyte reiterates $30M-$32M 2026 revenue outlook as Genentech partnership expands enterprise model · 2026-08-13
- Maxcyte, Inc. (MXCT) filed form 8-K · 2026-08-12 · SEC EDGAR
Ask the AI about MXCT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →